when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Moderna, Inc. ($MRNA) · news · pharmadog

← back to Moderna, Inc.

News mentioning $MRNA

102 stories

16dSTAT+: Could poop pills be the next treatment for food allergies?stat

16dSTAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safetystat

16dSTAT+: Moderna launches early trial of Ebola mRNA vaccinestat

16dSTAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and morestat

16dThe main therapy used for children with autism faces changes under Medicaidstat

17dBioNTech cuts sales forecast on slumping demand for COVID-19 vaccinebiospace

17dPfizer cuts $2.5B more across R&D, manufacturing in ongoing restructurebiospace

18dBioNTech taps Sobi executive Oelkers as its next CEObiopharma dive

18dSTAT+: Is there a pharma mega-merger in the making?stat

18dBioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotechbiospace

18dSTAT+: BioNTech names Guido Oelkers its new CEOstat

19dAfter 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA companyfiercebiotech

21dModerna maintains 10% growth target despite Phase 3 norovirus missbiospace

22dJ&J secures right to take the helm in up to $925M Sail CAR T pactbiospace

23dBiogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the storebiospace

26dFDA has recommitted to adcomms—but to what end?biospace

29dFDA panel confronting peptide controversystat

Jul 22, 266 companies hiring in Cambridge nowbiospace

Jul 20, 26Opinion: It’s time to treat pandemics as threats to national securitystat

Jul 17, 26Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesbiopharma dive

Jul 16, 26‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech

Jul 16, 26Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patentsendpoints

Jul 15, 26Cassidy grills Trump nominee on past vaccine comments in heated exchangestat

Jul 10, 26Nominee for key federal health role has a history of questioning vaccinesstat

Jul 1, 26FDA says Zyn can market its pouches as safer than cigarettesstat

Jun 30, 26STAT+: Abivax seeks to ease safety concerns with new data, boosting sharesstat

Jun 18, 26STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversystat

Jun 18, 26Moderna flu vaccine wins unanimous support from FDA panelbiopharma dive

Jun 16, 26FDA staff scrutinizes evidence supporting Moderna’s flu vaccinebiopharma dive

Jun 15, 26Covid vaccination cut risk of adverse heart events, large study findsstat

← prevpage 3 of 4next →